[1]
Ardalan ZS,Chandran S,Vasudevan A,Angus PW,Grigg A,He S,Macdonald GA,Strasser SI,Tate CJ,Kennedy GA,Testro AG,Gow PJ, Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver Disease. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2019 Nov;
[PubMed PMID: 31469227]
[2]
Wulf HC,Nissen CV,Philipsen PA, Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality. Photodiagnosis and photodynamic therapy. 2020 Mar;
[PubMed PMID: 31809913]
[3]
Wang P,Sachar M,Lu J,Shehu AI,Zhu J,Chen J,Liu K,Anderson KE,Xie W,Gonzalez FJ,Klaassen CD,Ma X, The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria. Science advances. 2019 Sep;
[PubMed PMID: 31555729]
Level 3 (low-level) evidence
[4]
Balwani M,Naik H,Anderson KE,Bissell DM,Bloomer J,Bonkovsky HL,Phillips JD,Overbey JR,Wang B,Singal AK,Liu LU,Desnick RJ, Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria. JAMA dermatology. 2017 Aug 1;
[PubMed PMID: 28614581]
[5]
Heerfordt IM,Lerche CM,Wulf HC, Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria - 20 years of follow-up. Photodiagnosis and photodynamic therapy. 2020 Jul 24;
[PubMed PMID: 32717453]
[6]
Snast I,Kaftory R,Sherman S,Edel Y,Hodak E,Levi A,Lapidoth M, Acquired erythropoietic protoporphyria: A systematic review of the literature. Photodermatology, photoimmunology
[PubMed PMID: 31374130]
Level 1 (high-level) evidence
[7]
Coffey A,Leung DH,Quintanilla NM, Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease. Pediatrics. 2018 Apr;
[PubMed PMID: 29610169]
[8]
Rutter KJ,Ashraf I,Cordingley L,Rhodes LE, Quality of life and psychological impact in the photodermatoses: a systematic review. The British journal of dermatology. 2020 May;
[PubMed PMID: 31278744]
Level 2 (mid-level) evidence
[9]
Edel Y,Mamet R,Snast I,Kaftory R,Mazor S,Hodak E,Lapidoth M,Elis A,Molad Y,Levi A, Epidemiology of cutaneous porphyria in Israel: a nationwide cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020 Jan;
[PubMed PMID: 31264284]
[10]
Edel Y,Mamet R, Porphyria: What Is It and Who Should Be Evaluated? Rambam Maimonides medical journal. 2018 Apr 19;
[PubMed PMID: 29553924]
[11]
Liu HM,Deng GH,Mao Q,Wang XH, Diagnosis of erythropoietic protoporphyria with severe liver injury: A case report. World journal of gastroenterology. 2019 Feb 21;
[PubMed PMID: 30809087]
Level 3 (low-level) evidence
[12]
McNeil MM,Nahhas AF,Braunberger TL,Hamzavi IH, Afamelanotide in the Treatment of Dermatologic Disease Skin therapy letter. 2018 Nov;
[PubMed PMID: 30517779]
Level 3 (low-level) evidence
[13]
Weiss Y,Balwani M,Chen B,Yasuda M,Nazarenko I,Desnick RJ, Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations. Molecular genetics and metabolism. 2019 Nov;
[PubMed PMID: 30454868]
[14]
Wang YM,Gloude NJ,Davies SM,Lucky AW,Nelson AS, Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric blood
[PubMed PMID: 34245225]
[15]
Hashmi SK,Harstead E,Sachdev M,Black DD,Clark I,Ortanca I,Triplett BM,Talleur AC, Hematopoietic cell transplant for reversal of liver fibrosis in a pediatric patient with erythropoietic protoporphyria. Pediatric transplantation. 2021 Sep;
[PubMed PMID: 33405342]
[16]
Endo Y,Hibi T,Shinoda M,Obara H,Kitago M,Yagi H,Abe Y,Hasegawa Y,Matsubara K,Hori S,Tanaka M,Makiuchi S,Nakano Y,Itano O,Kuroda T,Kitagawa Y, Reappraisal of liver transplantation for erythropoietic protoporphyria: A deadly combination of disease recurrence and biliary complication. Pediatric transplantation. 2022 Jun;
[PubMed PMID: 35225415]
[17]
Ricci A,Di Betto G,Bergamini E,Buzzetti E,Corradini E,Ventura P, Iron Metabolism in the Disorders of Heme Biosynthesis. Metabolites. 2022 Aug 31;
[PubMed PMID: 36144223]
[18]
de Castro Maqueda G,Gutiérrez-Manzanedo JV,González-Montesinos JL,Vaz Pardal C,Rivas Ruiz F,de Troya Martín M, Sun Exposure and Photoprotection: Habits, Knowledge and Attitudes Among Elite Kitesurfers. Journal of cancer education : the official journal of the American Association for Cancer Education. 2020 Jul 27;
[PubMed PMID: 32720132]
[19]
Balwani M, Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management. Molecular genetics and metabolism. 2019 Nov;
[PubMed PMID: 30704898]
[20]
Yoshida A,Hagiwara S,Watanabe T,Nishida N,Ida H,Sakurai T,Komeda Y,Yamao K,Takenaka M,Enoki E,Kimura M,Miyake M,Kawada A,Kudo M, Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy. Internal medicine (Tokyo, Japan). 2018;
[PubMed PMID: 30175727]